Understanding the Clinical Profile of Insulin Degludec, the Latest Basal Insulin Approved for Use in Canada: a Narrative Review

In recent years, the development of basal insulin therapies has focused on insulin analogues that have longer durations of action and more predictable pharmacokinetic/pharmacodynamic (PK/PD) profiles than their human insulin-based predecessors, such as neutral protamine Hagedorn (NPH) insulin. Dosed...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Vincent, Berard, Lori, Roscoe, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547940/
https://www.ncbi.nlm.nih.gov/pubmed/32940879
http://dx.doi.org/10.1007/s13300-020-00915-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547940/
https://www.ncbi.nlm.nih.gov/pubmed/32940879
http://dx.doi.org/10.1007/s13300-020-00915-w

Ejemplares similares